WallStreetZenWallStreetZen

NASDAQ: CTY
City Therapeutics Inc Stock Ownership - Who owns City Therapeutics?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have City Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Arch Venture Partners XII LLC10% Owner2026-10-19170,000$18.00
$3.06MBuy
Robert NelsenDirector2026-10-19170,000$18.00
$3.06MBuy

1 of 1

CTY insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTY insiders and whales buy or sell their stock.

CTY Shareholders

What type of owners hold City Therapeutics Inc stock?

No data
There are no institutional or insider shareholders.

CTY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AARD0.04%46.39%Net SellingNet Selling
ACET0.04%99.96%Net Buying
ABVC0.00%78.89%
ABVX0.07%0.00%
TRXB0.00%37.74%Net BuyingNet Buying
View Top Biotech Stocks

City Therapeutics Stock Ownership FAQ

Who owns City Therapeutics?

City Therapeutics (NASDAQ: CTY) is owned by 0.00% institutional shareholders, 62.22% City Therapeutics insiders, and 37.78% retail investors.

If you're new to stock investing, here's how to buy City Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.